1. India Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
Sunil Healthcare Ltd.

Sunil Healthcare Ltd.

64.10
INR
-0.90
(-1.38%)
3.47EPS
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
59.37
70.31
78.9
98.36
87.28
78.24
67.81
88.08
116.2
107.71
87.92
81.31
85.29
81.86
Basic EPS, GAAP
3.2
3.88
5.1
4.91
4.38
-0.67
-4.84
-0.62
6.26
6.52
-1.74
-1.38
3.91
3.47
Free Cash Flow per Basic Share
4.99
-1.93
-6.54
-2.45
-9.88
8.92
3.41
9.89
13.14
3.19
-25.22
2.04
18.1
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
22.55
25.23
30.29
41.84
46.26
45.61
43.49
42.63
48.71
54.61
66.52
65.4
67.87
- -
Tangible Book Value per Share
22.34
25.06
30.13
41.52
45.98
45.3
43.25
42.44
48.55
54.49
66.44
65.36
67.85
- -
Basic Weighted Avg Shares
10
10
10
10
10
10
10
10
10
10
10
10
10
10
Sales/Revenue/Turnover
609
721
809
1,009
895
802
695
903
1,192
1,105
902
834
875
841
Operating Margin (%)
14.36
11.36
13.51
10.92
10.87
6.96
-14.35
5.16
13.82
11.08
-1.35
7.96
9.53
7.35
Depreciation Expense
41
40
38
43
48
57
61
61
63
70
61
64
64
62
Net Income, GAAP
33
40
52
50
45
-7
-50
-6
64
67
-18
-14
40
36
Effective Tax Rate (%)
35.93
35.33
34.93
36.23
28.79
- -
- -
- -
30.7
29.54
- -
- -
- -
- -
Profit Margin (%)
5.39
5.52
6.46
4.99
5.02
-0.86
-7.14
-0.71
5.39
6.05
-1.98
-1.7
4.58
4.24
Working Capital
18
39
26
5
7
-86
-72
-50
-50
26
52
25
75
- -
LT Debt
38
57
92
128
183
97
120
148
110
86
189
179
137
- -
Total Equity
231
259
311
429
474
468
446
437
500
560
682
671
696
- -
Return on Invested Capital (%)
7.68
8.52
8.76
7.15
7.15
- -
- -
- -
9.4
9.65
- -
- -
- -
- -
Return on Capital (%)
11.03
11.47
12.26
9.72
7.83
- -
- -
- -
9.24
10.25
- -
- -
- -
- -
Return on Common Equity (%)
15.26
16.25
18.36
13.6
9.95
-1.47
-10.86
-1.44
13.71
12.61
-2.88
-2.09
5.86
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
403
- -
LT Borrowings
- -
137
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
10
10
10
Market Capitalization
- -
- -
- -

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
739
- -
Cash, Cash Equivalents & STI
- -
1
- -
Accounts Receivable, Net
- -
451
- -
Inventories
- -
187
- -
Total Current Liabilities
- -
663
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
403
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.09%
10.05%
3.78%
Free Cash Flow
-7.51%
-50.8%
788.66%
Net Income, GAAP
-123.2%
-326.56%
-382.79%
Sales/Revenue/Turnover
2.32%
0.72%
4.9%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
215
203
205
212
834
2026
226
235
218
197
875
2027
190
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.67
-0.53
-0.53
0.35
-1.38
2026
0.89
0.97
0.57
1.48
3.91
2027
0.45
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Anil Kumar Khaitan
Full Time Employees
158
Sector
Health technology
Industry
Pharmaceuticals: major
Address
38E/252-A, Vijay Tower New Delhi DE India 110049
IPO Date
Jan 23, 2014
Website
sunilhealthcare.com
Similar Companies
Eli Lilly and Company (NYSE:LLY)
Novo Nordisk A/S (NYSE:NVO)
Johnson & Johnson (NYSE:JNJ)
Pfizer, Inc. (NYSE:PFE)
Dr. Reddy's Laboratories Ltd. (NSE:DRREDDY)
Divi's Laboratories Limited (NSE:DIVISLAB)
Business
Sunil Healthcare Limited manufactures empty hard gelatin capsule shells, vegetable capsules, pullulan capsules, and HPMC vegan capsules under the Sunloc brand; it offers specialized features including double lock, triple lock, multiple groove designs, liner options, circular printing, two-color printing, and 360-degree printing across nine sizes with a production capacity of 13 billion capsules per annum. The company, founded in 1973 and headquartered in New Delhi, India, with manufacturing facilities in Alwar, Rajasthan, operates primarily in the pharmaceutical packaging sector, serving domestic and global markets as the second-largest producer of empty hard shell gelatin capsules in India. In recent developments, Sunil Healthcare appointed Mr. Jai Prakash Singh as an additional non-executive independent director effective February 13, 2025, for a five-year term; approved remuneration for Chairman and Managing Director Mr. Anil Kumar Khaitan through March 31, 2027; and named M/s. ATCS & Associates as secretarial auditors for five years and M/s. MUFG Intime India Private Limited for e-voting services at its 51st annual general meeting held on September 29, 2025.